diarrhea from retatrutide Unapproved weight loss drug causes extreme side effects Retatrutide-Induced Intractable Diarrhea | Annals

Protocol (adapted from ref 12) 1

The use of mitochondria-targeted tri-catechol-based iron chelators, in combination with mitochondria-homing Szeto-Schiller (SS) peptides, enables the precise delivery of iron-selective chelating agents to mitochondria

Photodegradation of polystyrene films containing UV-visible sensitizers

Tirzepatide (GLP-1 + GIP) supports appetite control and structured medical weight loss under physician supervision

About 1.6 million adults in England, Scotland and Wales are estimated to have used GLP-1s for weight loss between early 2024 and early 2025, according to recently published research by University College London